Test Price
2,800 AEDโ Home Collection Available
PRKAR1A Gene Carney Complex Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM โ 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PRKAR1A gene NGS test identifies pathogenic variants associated with Carney Complex Type 1, a hereditary syndrome predisposing to myxomas, endocrine tumors, and pigmented skin lesions. Early detection enables proactive surveillance and family risk assessment.
Prior to testing, a genetic counseling session is advised to construct a detailed family pedigree; please share your complete clinical history with our phlebotomist.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% wide coverage of all exons and splice sites | ~98% for targeted single variants, limited coverage |
| Method | Next-Generation Sequencing (Illumina platform) | Sanger sequencing of individual exons |
| Speed | 3โ4 Weeks | 6โ8 Weeks (if multiple fragments) |
Physician Insight & Safety Protocols
"The PRKAR1A gene test is a powerful tool for identifying hereditary risk of Carney Complex Type 1, especially in families with a history of cardiac myxomas or endocrine tumors. However, clinical correlation with personal and family history remains essential. I recommend discussing all results with a qualified genetic counselor before making any medical decisions." โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medications without consulting your physician. Genetic test results influence surveillance recommendations but never replace ongoing medical management for existing conditions.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unwilling or unable to provide informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability; minors require legal guardian consent.
- Exclusion: Insufficient blood/DNA sample quality; severe anemia or active infection may require rescheduling.
- ER Red Flag: If the report identifies a known pathogenic variant and you experience new cardiac symptoms (palpitations, chest pain, shortness of breath), seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the PRKAR1A gene test detect and who should consider it?
This test detects all pathogenic variants in the PRKAR1A gene, identifying hereditary Carney Complex Type 1 risk for endocrine tumors and cardiac myxomas. It is recommended for individuals with a family history of Carney Complex or suggestive clinical features such as myxomas, spotty skin pigmentation, or endocrine overactivity.
2. How is the sample collected and what is the turnaround time?
A simple blood draw is collected via VIP Mobile Phlebotomy at your home (available daily 8 AM โ 11 PM). The sample is processed using nextโgeneration sequencing, with results delivered within 3โ4 weeks.
3. Will insurance cover this test and how can I verify coverage?
Many UAE insurers cover genetic testing for familial cancer syndromes. To verify direct billing, contact our billing team via WhatsApp at +971 54 548 8731 with your policy details.
UAE Regulatory & Data Privacy Adherence
This test strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored securely. Sample handling follows ISO 9001:2015 certified processes (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | PRKAR1A Gene Sequencing (Carney Complex Type 1) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3โ5 mL in EDTA tube) or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (Illumina platform) |
| ICD-10-CM Code | E31.9 (Multiple endocrine neoplasia, unspecified) |
| LOINC Code | 82941-0 (PRKAR1A gene sequencing) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians